Back to search
FDAFDA · Food and drugs·Recall number D-913-2013

Nystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771

Published August 28, 2013 · Recall initiated: July 4, 2013

Summary

FDA records drug Class II recall D-913-2013, published August 28, 2013 and initiated July 4, 2013. Recalling firm: VistaPharm, Inc.; Status: Terminated; Reported quantity: 1,707,050 cups / 5ml ea.; Lot: Lot # 240200, 243000, 244800, 245600, 250800 and 253600. Exp 06/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
VistaPharm, Inc.
Distributor
Nationwide.
Lot
Lot # 240200, 243000, 244800, 245600, 250800 and 253600. Exp 06/13.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771 recalled?

Yes. FDA published recall D-913-2013 on August 28, 2013. Reported hazard: Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit